Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021

BACKGROUND: The efficacy of messenger RNA (mRNA)–1273 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is not well defined, particularly among young adults. METHODS: Adults aged 18–29 years with no known history of SARS-CoV-2 infection or prior vaccination for coronavir...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephenson, Kathryn E, Marcelin, Jasmine R, Pettifor, Audrey E, Janes, Holly, Brown, Elizabeth, Neradilek, Moni, Yen, Catherine, Andriesen, Jessica, Grunenberg, Nicole, Espy, Nicole, Trahey, Meg, Fischer, Rebecca S B, DeSouza, Christopher A, Shisler, Joanna L, Connick, Elizabeth, Houpt, Eric R, Chu, Helen Y, McCulloh, Russel J, Becker-Dreps, Sylvia, Vielot, Nadja A, Kalbaugh, Corey A, Cherabuddi, Kartik, Krueger, Karen M, Rosenberg, Molly, Greenberg, Richard N, Joaquin, Arnel, Immergluck, Lilly Cheng, Corey, Lawrence, Kublin, James G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655942/
https://www.ncbi.nlm.nih.gov/pubmed/38023544
http://dx.doi.org/10.1093/ofid/ofad511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655942/
https://www.ncbi.nlm.nih.gov/pubmed/38023544
http://dx.doi.org/10.1093/ofid/ofad511

Ejemplares similares